Mato, A. R., Sharman, J. P., Biondo, J. M., Wu, M., Mun, Y., Kim, S. Y., Humphrey, K., Boyer, M., Zhu, Q. and Seymour, J. F. (2020) “The impact of early discontinuation/dose modification of venetoclax on outcomes in patients with relapsed/refractory chronic lymphocytic leukemia: <i>post-hoc</i&gt; analyses from the phase III MURANO study”, Haematologica. Pavia, Italy, 107(1), pp. 134-142. doi: 10.3324/haematol.2020.266486.